Mutations of calpain 3 gene in patients with sporadic limb-girdle muscular dystrophy in Japan

Journal of the Neurological Sciences

Volumn 171, Issue 1, 1999, Pages 31-37

  Minami, Narihiro ^a,b   Nishino, Ichizo ^b   Kobayashi, Osamu ^a,b   Ikezoe, Koji ^b   Goto, Yu Ichi ^b   Nonaka, Ikuya ^a,b  

^a National Center of Neurology and Psychiatry   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

Calpain 3; LGMD2A; Limb girdle muscular dystrophy; Molecular diagnosis; p94; Sporadic case

Indexed keywords

CALPAIN; MESSENGER RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; ENZYME DEFICIENCY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; JAPAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD;

EID: 0032725074     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00245-2     Document Type: Article

References (40)

1. Walton J.N., Nattrass F.J. On the classification, natural history and treatment of the myopathies. Brain. 77:1954;169-231.
2. Bushby K.M.D., Beckmann J.S. The limb-girdle muscular dystrophies - proposal for a new nomenclature (Report of the 30th and 31st ENMC international workshop). Neuromuscular Disord. 5:1995;337-343.
3. Beckmann J.S., Bushby K.M.D. Advances in the molecular genetics of the limb-girdle type of autosomal recessive progressive muscular dystrophy. Curr Opin Neurol. 9:1996;389-393.
4. van der Kooi A.J., van Meegan M., Ledderhof T.M., McNally E.M., de Visser M., Bolhuis P.A. Genetic localization of a newly recognized autosomal dominant limb-girdle muscular dystrophy with cardiac involvement (LGMD1B) to chromosome 1q11-21. Am J Hum Genet. 60:1997;891-895.
5. Minetti C., Sotgia F., Bruno C., Scartezzini P., Broda P., Bado M., Masetti E., Mazzocco M., Egeo A., Donati M.A., Volonté D., Galbiati F., Cordone G., Bricarelli F.D., Lisanti M.P., Zara F. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet. 18:1998;365-368.
6. Moreira E.S., Vainzof M., Marie S.K., Sertié A.L., Zatz M., Passos-Bueno M.R. The seventh form of autosomal recessive limb-girdle muscular dystrophy is mapped to 17q11-12. Am J Hum Genet. 61:1997;151-159.
7. Weiler T., Greenberg C.R., Zelinski T., Nylen E., Coghlan G., Crumley M.J., Fujiwara T.M., Morgan K., Wrogemann K. A gene for autosomal recessive limb-girdle muscular dystrophy in Manitoba Hutterites maps to chromosome region 9q31-q33: evidence for another limb-girdle muscular dystrophy locus. Am J Hum Genet. 63:1998;140-147.
8. Speer M.C., Vance J.M., Grubber J.M., Lennon Graham F., Stajich J.M., Viles K.D., Rogala A., McMichael R., Chutkow J., Goldsmith C., Tim R.W., Pericak-Vance M.A. Identification of a new autosomal dominant limb-girdle muscular dystrophy locus on chromosome 7. Am J Hum Genet. 64:1999;556-562.
9. Noguchi S., McNally E.M., Ben Othmane K., Hagiwara Y., Mizuno Y., Yoshida M., Yamamoto H., Bönemann C.G., Gussoni E., Denton P.H., Kyriakides T., Middleton L., Hentati F., Ben Hamida M., Nonaka I., Vance J.M., Kunkel L.M., Ozawa E. Mutations in the dystrophin-associated protein γ-sarcoglycan in chromosome 13 muscular dystrophy. Science. 270:1995;819-822.
10. Piccolo F., Roberds S.L., Jeanpierre M., Leturcq F., Azibi K., Beldjord C., Carrié A., Récan D., Chaouch M., Reghis A., el Kerch F., Sefiani A., Voit T., Merlini L., Collin H., Eymard B., Beckmann J.S., Romero N.B., Tomé F.M.S., Fardeau M., Campbell K.P., Kaplan J.C. Primary adhalinopathy: a common cause of autosomal recessive muscular dystrophy of variable severity. Nat Genet. 10:1995;243-245.
11. Bönnemann C.G., Modi R., Noguchi S., Mizuno Y., Yoshida M., Gussoni E., McNally E.M., Duggan D.J., Angelini C., Hoffman E.P., Ozawa E., Kunkel L.M. β-Sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet. 11:1995;266-272.
12. Lim L.E., Duclos F., Broux O., Bourg N., Sunada Y., Allamand V., Meyer J., Richard I., Moomaw C., Slaughter C., Tomé F.M.S., Fardeau M., Jackson C.E., Beckmann J.S., Campbell K.P. β-Sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat Genet. 11:1995;257-265.
13. Nigro V., de Sà Moreira E., Piluso G., Vainzof M., Belsito A., Politano L., Puca A.A., Passos-Bueno M.-R., Zatz M. Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the δ-sarcoglycan gene. Nat Genet. 14:1996;195-198.
14. Mizuno Y., Noguchi S., Yamamoto H., Yoshida M., Suzuki A., Hagiwara Y., Hayashi Y.K., Arahata K., Nonaka I., Hirai S., Ozawa E. Selective defect of sarcoglycan complex in severe childhood autosomal recessive muscular dystrophy. Biochem Biophys Res Commun. 204:1994;979-983.
15. Richard I., Broux O., Allamand V., Fougerousse F., Chiannilkulchai N., Bourg N., Brenguier L., Devaud C., Pasturaud P., Roudaut C., Hillaire D., Passos-Bueno M.-R., Zats M., Tischfield J.A., Fardeau M., Jackson C.E., Cohen D., Beckmann J.S. Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell. 81:1995;27-40.
16. Murachi T. Intracellular regulatory system involving calpain and calpastatin. Biochem Int. 18:1989;263-294.
17. Croall D.E., DeMartino G.N. Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol Rev. 71:1991;813-847.
18. Suzuki K., Sorimachi H., Yoshizawa T., Kinbara K., Ishiura S. Calpain: novel family members, activation, and physiologic function. Biol Chem Hoppe Seyler. 376:1995;523-529.
19. Sorimachi H., Imajoh-Ohmi S., Emori Y., Kawasaki H., Ohno S., Minami Y., Suzuki K. Molecular cloning of a novel mammalian calcium-dependent protease distinct from both m- and μ-types: specific expression of the mRNA in skeletal muscle. J Biol Chem. 264:1989;20106-20111.
20. Sorimachi H., Toyama-Sorimachi N., Saido T.C., Kawasaki H., Sugita H., Miyasaka M., Arahata K., Ishiura S., Suzuki K. Muscle-specific calpain, p94, is degraded by autolysis immediately after translation, resulting in disappearance from muscle. J Biol Chem. 268:1993;10593-10605.
21. Sorimachi H., Kinbara K., Kimura S., Takahashi M., Ishiura S., Sasagawa N., Sorimachi N., Shimada H., Tagawa K., Maruyama K., Suzuki K. Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94-specific sequence. J Biol Chem. 270:1995;31158-31162.
22. Sorimachi H., Kimura S., Kinbara K., Kazama J., Takahashi M., Yajima H., Ishiura S., Sasagawa N., Nonaka I., Sugita H., Maruyama K., Suzuki K. Structure and physiological functions of ubiquitous and tissue-specific calpain species: muscle-specific calpain, p94, interacts with connectin/titin. Adv Biophys. 33:1996;101-122.
23. Richard I., Brenguier L., Dinçer P., Roudaut C., Bady B., Burgunder J.-M., Chemaly R., Garcia C.A., Halaby G., Jackson C.E., Kurnit D.M., Lefranc G., Legum C., Loiselet J., Merlini L., Nivelon-Chevallier A., Ollagnon-Roman E., Restagno G., Topaloglu H., Beckmann J.S. Multiple independent molecular etiology for limb-girdle muscular dystrophy type 2A patients from various geographical origins. Am J Hum Genet. 60:1997;1128-1138.
24. Passos-Bueno M.R., Moreira E.S., Marie S.K., Bashir R., Vasquez L., Love D.R., Vainzof M., Iughetti P., Oliveira J.R., Bakker E., Strachan T., Bushby K., Zatz M. Main clinical features of the three mapped autosomal recessive limb-girdle muscular dystrophies and estimated proportion of each form in 13 Brazilian families. J Med Genet. 33:1996;97-102.
25. Dinçer P., Leturcq F., Richard I., Piccolo F., Yalnizoglu D., de Toma C., Akçören Z., Broux O., Deburgrave N., Brenguier L., Roudaut C., Urtizberea J.A., Jung D., Tan E., Jeanpierre M., Campbell K.P., Kaplan J.C., Beckmann J.S., Topaloglu H. A biochemical, genetic, and clinical survey of autosomal recessive limb girdle muscular dystrophies in Turkey. Ann Neurol. 42:1997;222-229.
26. Kawai H., Akaike M., Kunishige M., Inui T., Adachi K., Kimura C., Kawajiri M., Nishida Y., Endo I., Kashiwagi S., Nishino H., Fujiwara T., Okuno S., Roudaut C., Richard I., Beckmann J.S., Miyoshi K., Matsumoto T. Clinical, pathological, and genetic features of limb-girdle muscular dystrophy type 2A with new calpain 3 gene mutations in seven patients from three Japanese families. Muscle Nerve. 21:1998;1493-1501.
27. Yamanouchi Y., Arikawa E., Arahata K., Ozawa E., Nonaka I. Limb-girdle muscular dystrophy: clinical and pathologic reevaluation. J Neurol Sci. 129:1995;15-20.
28. Mahjneh I., Bushby K., Pizzi A., Bashir R., Marconi G. Limb-girdle muscular dystrophy: a follow-up study of 79 patients. Acta Neurol Scand. 94:1996;177-189.
29. Anderson L.V., Davison K., Moss J.A., Richard I., Fardeau M., Tomé F.M., Hübner C., Lasa A., Colomer J., Beckmann J.S. Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A. Am J Pathol. 153:1998;1169-11679.
30. Sorimachi H., Suzuki K. Sequence comparison among muscle-specific calpain, p94, and calpain subunits. Biochim Biophys Acta. 1160:1992;55-62.
31. 2+-binding domain. J Biol Chem. 268:1993;19476-19482.
32. Richard I., Beckmann J.S. Molecular cloning of mouse canp3, the gene associated with limb-girdle muscular dystrophy 2A in human. Mamm Genome. 7:1996;377-379.
33. Ono Y., Shimada H., Sorimachi H., Richard I., Saido T.C., Beckmann J.S., Ishiura S., Suzuki K. Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A. J Biol Chem. 273:1998;17073-17078.
34. Chou F.L., Angelini C., Daentl D., Garcia C., Greco C., Hausmanowa-Petrusewicz I., Fidzianska A., Wessel H., Hoffman E.P. Calpain III mutation analysis of a heterogeneous limb-girdle muscular dystrophy population. Neurology. 52:1999;1015-1020.
35. Fardeau M., Hillaire D., Mignard C., Feingold N., Feingold J., Mignard D., de Ubeda B., Collin H., Tomé F.M., Richard I., Beckmann J. Juvenile limb-girdle muscular dystrophy. Clinical, histopathological and genetic data from a small community living in the Réunion Island. Brain. 119:1996;295-308.
36. Passos-Bueno M.R., Vainzof M., Moreira E.S., Zatz M. Seven autosomal recessive limb-girdle muscular dystrophies in the Brazilian population: from LGMD2A to LGMD2G. Am J Med Genet. 82:1999;392-398.
37. Hayashi Y.K., Mizuno Y., Yoshida M., Nonaka I., Ozawa E., Arahata K. The frequency of patients with 50-Kd dystrophin-associated glycoprotein (50DAG or adhalin) deficiency in a muscular dystrophy patient population in Japan: immunocytochemical analysis of 50DAG, 43DAG, dystrophin, and utrophin. Neurology. 45:1995;551-554.
38. Sewry C.A., Taylor J., Anderson L.V., Ozawa E., Pogue R., Piccolo F., Bushby K., Dubowitz V., Muntoni F. Abnormalities in alpha-, beta- and gamma-sarcoglycan in patients with limb-girdle muscular dystrophy. Neuromuscular Disord. 6:1996;467-474.
39. Duggan D.J., Gorospe J.R., Fanin M., Hoffman E.P., Angelini C. Mutations in the sarcoglycan genes in patients with myopathy. New Engl J Med. 336:1997;618-624.
40. Fanin M., Duggan D.J., Mostacciuolo M.L., Martinello F., Freda M.P., Soraru G., Trevisan C.P., Hoffman E.P., Angelini C. Genetic epidemiology of muscular dystrophies resulting from sarcoglycan gene mutations. J Med Genet. 34:1997;973-977.